D. Hannaman

469 total citations
10 papers, 342 citations indexed

About

D. Hannaman is a scholar working on Biotechnology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, D. Hannaman has authored 10 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Biotechnology, 4 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in D. Hannaman's work include Microbial Inactivation Methods (5 papers), Transgenic Plants and Applications (4 papers) and Bacillus and Francisella bacterial research (3 papers). D. Hannaman is often cited by papers focused on Microbial Inactivation Methods (5 papers), Transgenic Plants and Applications (4 papers) and Bacillus and Francisella bacterial research (3 papers). D. Hannaman collaborates with scholars based in United States, Germany and Canada. D. Hannaman's co-authors include Sylvia van Drunen Littel‐van den Hurk, Barry Ellefsen, Alain Luxembourg, R Bernard, Jay W. Hooper, Connie S. Schmaljohn, Kristopher Paolino, Matthew Josleyn, James E. Moon and Klaus Überla and has published in prestigious journals such as Scientific Reports, Vaccine and Clinical Microbiology and Infection.

In The Last Decade

D. Hannaman

10 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Hannaman United States 9 133 130 98 81 77 10 342
Ina Baļķe Latvia 12 98 0.7× 112 0.9× 128 1.3× 49 0.6× 125 1.6× 26 484
Jieying Bai China 12 113 0.8× 73 0.6× 61 0.6× 34 0.4× 23 0.3× 25 274
Janess Mendoza United States 11 94 0.7× 120 0.9× 110 1.1× 65 0.8× 102 1.3× 12 338
Minerva Cervantes-Gonzalez France 4 103 0.8× 38 0.3× 69 0.7× 118 1.5× 35 0.5× 5 277
Javier Fuenmayor Spain 6 87 0.7× 42 0.3× 176 1.8× 47 0.6× 55 0.7× 6 324
Trina Racine Canada 14 235 1.8× 59 0.5× 95 1.0× 140 1.7× 37 0.5× 27 409
Alexander S. Belyaev United States 6 109 0.8× 41 0.3× 163 1.7× 89 1.1× 43 0.6× 8 357
Robert J. Drape United States 6 99 0.7× 171 1.3× 99 1.0× 189 2.3× 25 0.3× 8 361
Vesna Brusic United States 10 240 1.8× 90 0.7× 145 1.5× 112 1.4× 15 0.2× 13 446
Sharmila Manoj United States 6 53 0.4× 144 1.1× 77 0.8× 196 2.4× 14 0.2× 9 332

Countries citing papers authored by D. Hannaman

Since Specialization
Citations

This map shows the geographic impact of D. Hannaman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Hannaman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Hannaman more than expected).

Fields of papers citing papers by D. Hannaman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Hannaman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Hannaman. The network helps show where D. Hannaman may publish in the future.

Co-authorship network of co-authors of D. Hannaman

This figure shows the co-authorship network connecting the top 25 collaborators of D. Hannaman. A scholar is included among the top collaborators of D. Hannaman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Hannaman. D. Hannaman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Miller, Aleisha, D. Hannaman, Peter Hayes, et al.. (2017). Combined skin and muscle vaccination differentially impact the quality of effector T cell functions: the CUTHIVAC-001 randomized trial. Scientific Reports. 7(1). 13011–13011. 24 indexed citations
3.
Hooper, Jay W., James E. Moon, Kristopher Paolino, et al.. (2014). A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation. Clinical Microbiology and Infection. 20. 110–117. 50 indexed citations
4.
Fowler, Veronica L., Lucy Robinson, Sarah J. Cox, et al.. (2012). A DNA vaccination regime including protein boost and electroporation protects cattle against foot-and-mouth disease. Antiviral Research. 94(1). 25–34. 27 indexed citations
5.
Mpendo, Juliet, Annet Nanvubya, Etienne Karita, et al.. (2012). Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda. Retrovirology. 9(S2). 1 indexed citations
7.
Hurk, Sylvia van Drunen Littel‐van den & D. Hannaman. (2010). Electroporation for DNA immunization: clinical application. Expert Review of Vaccines. 9(5). 503–517. 69 indexed citations
8.
Hurk, Sylvia van Drunen Littel‐van den, et al.. (2008). Electroporation-based DNA transfer enhances gene expression and immune responses to DNA vaccines in cattle. Vaccine. 26(43). 5503–5509. 26 indexed citations
9.
Luxembourg, Alain, D. Hannaman, Emma Nolan, et al.. (2008). Potentiation of an anthrax DNA vaccine with electroporation. Vaccine. 26(40). 5216–5222. 32 indexed citations
10.
Luxembourg, Alain, et al.. (2005). Enhancement of immune responses to an HBV DNA vaccine by electroporation. Vaccine. 24(21). 4490–4493. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026